Effects of mirabegron on JJ stent-related symptoms: A multicentric study.

Author: , BozkurtOzan, CinarOnder, CizmeciSezer, ErbatuOguzcan, GirginReha, IrerBora, KizilayFuat, OngunSakir, OzdemirTuran, OzerSelcuk, SenVolkan, TanidirYiloren, UcerOktay

Paper Details 
Original Abstract of the Article :
AIMS OF THE STUDY: To investigate the effect of mirabegron 50 mg/daily for JJ stent-related symptoms after ureteroscopic stone surgery. METHODS: Medical records of 145 patients who were given a single daily oral dose of 50 mg of mirabegron for relieving stent-related symptoms were retrospectively a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/ijcp.13857

データ提供:米国国立医学図書館(NLM)

Mirabegron's Impact on JJ Stent Symptoms: A Multicentric Study

The field of urology is constantly evolving to improve patient outcomes after procedures like ureteroscopic stone surgery. This study, conducted in Turkey, focused on the effectiveness of mirabegron, a medication often used to treat overactive bladder, in managing symptoms associated with JJ stents, which are often placed after such surgeries. The researchers used a retrospective analysis of medical records from 145 patients who received mirabegron daily. They found that mirabegron significantly reduced the severity of stent-related symptoms, improving patients' quality of life. This is a promising finding, as it suggests that mirabegron could be a valuable tool for managing these uncomfortable side effects.

Mirabegron's Positive Impact on Stent-Related Symptoms

The research demonstrated that mirabegron significantly improved the quality of life for patients who underwent ureteroscopic stone surgery. Patients experienced a marked reduction in urinary symptoms, body pain, and general health scores. This is a significant finding, as it suggests that mirabegron could be a valuable tool for managing the discomfort often associated with JJ stents.

Potential for Improved Patient Care

This research is particularly encouraging for patients who have undergone ureteroscopic stone surgery. The results suggest that mirabegron could effectively minimize stent-related symptoms, leading to greater comfort and improved overall well-being. The findings suggest that mirabegron may offer a valuable solution for managing these symptoms, contributing to a smoother post-operative recovery.

Dr. Camel's Conclusion

Just like a camel traversing the vast desert, mirabegron seems to provide relief from the discomfort of JJ stents, leading to a smoother journey for patients. This study provides valuable insights into managing stent-related symptoms, suggesting that mirabegron could improve patient outcomes following ureteroscopic stone surgery.

Date :
  1. Date Completed 2021-04-27
  2. Date Revised 2021-04-27
Further Info :

Pubmed ID

33230894

DOI: Digital Object Identifier

10.1111/ijcp.13857

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.